Cargando…

Incidence trends for epithelial peritoneal, ovarian, and fallopian tube cancer during 1999–2016: a retrospective study based on the Korean National Cancer Incidence Database

OBJECTIVE: Primary peritoneal cancer (PPC), ovarian cancer (OC), and fallopian tube cancer (FTC) are considered as a single disease group. As knowledge of the pathogenesis and clinical presentation of peritoneal, ovarian, and fallopian tube (POFT) cancer grows, the tendencies in OC diagnosis are cha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shin, Wonkyo, Won, Young Joo, Yoo, Chong Woo, Lim, Jiwon, Lim, Myong Cheol
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7286760/ https://www.ncbi.nlm.nih.gov/pubmed/32266805 http://dx.doi.org/10.3802/jgo.2020.31.e56

Ejemplares similares

Second primary cancer after primary peritoneal, epithelial ovarian, and fallopian tubal cancer: a retrospective study
por: Lim, Myong Cheol, et al.
Publicado: (2018)

Second Primary Ovarian Epithelial, Fallopian Tube, and Primary Peritoneal Cancers after Breast Cancer Diagnosis: Korea Central Cancer Registry
por: Ha, Hyeong In, et al.
Publicado: (2021)

Peritoneal cancer index in ovarian cancer
por: Shin, Wonkyo, et al.
Publicado: (2018)

Incidence of epithelial ovarian cancer according to histologic subtypes in Korea, 1999 to 2012
por: Kim, Se Ik, et al.
Publicado: (2016)

The incidence and survival of cervical, ovarian, and endometrial cancer in Korea, 1999-2017: Korea Central Cancer Registry
por: Ha, Hyeong In, et al.
Publicado: (2021)

Incidence and treatment outcomes of uterine cervical cancer in Korea 1999–2018 from the national cancer registry
por: Suh, Dong Hoon, et al.
Publicado: (2023)

Reclassification of BRCA1 and BRCA2 variants found in ovarian epithelial, fallopian tube, and primary peritoneal cancers
por: Ha, Hyeong In, et al.
Publicado: (2020)

Development and Validation of Ovarian Symptom Index-18 and Neurotoxicity-4 for Korean Patients with Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
por: Lee, Maria, et al.
Publicado: (2019)

Correction of Funding information: The incidence and survival of cervical, ovarian, and endometrial cancer in Korea, 1999–2017: Korea Central Cancer Registry
por: Ha, Hyeong In, et al.
Publicado: (2022)

Position statements on genetic test for peritoneal, ovarian, and fallopian tubal cancers: Korean Society of Gynecologic Oncology (KSGO)
por: Choi, Min Chul, et al.
Publicado: (2016)

Incidence of venous thromboembolism after standard treatment in patients with epithelial ovarian cancer in Korea
por: Shin, Wonkyo, et al.
Publicado: (2021)

Incidence of cervical, endometrial, and ovarian cancer in Korea during 1999–2015
por: Lim, Myong Cheol, et al.
Publicado: (2018)

Incidence of cervical, endometrial, and ovarian cancer in Korea, 1999-2010
por: Lim, Myong Cheol, et al.
Publicado: (2013)

Discussing maintenance therapy for ovarian, peritoneal, and fallopian tube cancers
por: Mercier, Ann Marie, et al.
Publicado: (2023)

Peritoneal Dialysis Catheter−Fallopian Tube Fistula
por: Mandalapu, Rajendra, et al.
Publicado: (2020)

Uterine Cancer Incidence and Mortality — United States, 1999–2016
por: Henley, S. Jane, et al.
Publicado: (2018)

Bilateral salpingectomy to reduce the risk of ovarian/fallopian/peritoneal cancer in women at average risk: a position statement of the Korean Society of Obstetrics and Gynecology (KSOG)
por: Kim, Miseon, et al.
Publicado: (2018)

Tumorigenesis and peritoneal colonization from fallopian tube epithelium
por: Eddie, Sharon L., et al.
Publicado: (2015)

Incidence of Hypersensitivity Reactions to Carboplatin or Paclitaxel in Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer With or Without BRCA1 or BRCA2 Mutations
por: Garcia, Andrew, et al.
Publicado: (2019)

Incidence of gastrointestinal perforation associated with bevacizumab in combination with neoadjuvant chemotherapy as first-line treatment of advanced ovarian, fallopian tube, or peritoneal cancer: analysis of a Japanese healthcare claims database
por: Ueda, Akihiko, et al.
Publicado: (2022)

Clinical relevance of circulating tumor cells in ovarian, fallopian tube and peritoneal cancer
por: Banys-Paluchowski, Malgorzata, et al.
Publicado: (2020)

Incidence and survival of epithelial ovarian, fallopian tube, peritoneal, and undesignated abdominal/pelvic cancers in Sweden 1960–2014: A population-based cohort study
por: Leandersson, Pia, et al.
Publicado: (2021)

Stage–specific incidence trends of renal cancers in the East of England, 1999–2016
por: Herbert, Annie, et al.
Publicado: (2021)

Epothilones in epithelial ovarian, fallopian tube, or primary peritoneal cancer: a systematic review
por: Zagouri, Flora, et al.
Publicado: (2015)

Paraganglioma of the Fallopian Tube Presenting as Isolated Fallopian Tube Torsion
por: Takeda, Akihiro, et al.
Publicado: (2022)

Bevacizumab toxicity in heavily pretreated recurrent epithelial ovarian, fallopian tube, and primary peritoneal cancers
por: Martin, Jovana Y., et al.
Publicado: (2016)

The 2020 Japan Society of Gynecologic Oncology guidelines for the treatment of ovarian cancer, fallopian tube cancer, and primary peritoneal cancer
por: Tokunaga, Hideki, et al.
Publicado: (2021)

Outcomes and Prognostic Factors of Patients with Platinum-Resistant or Refractory Epithelial Ovarian Cancer, Fallopian Tube Cancer and Peritoneal Cancer
por: Hamontri, Suttha, et al.
Publicado: (2023)

Duplication of the fallopian tube
por: R, Narayanan, et al.
Publicado: (2008)

Diseases of the Fallopian Tubes
Publicado: (1885)

A phase Ib trial of docetaxel, carboplatin and erlotinib in ovarian, fallopian tube and primary peritoneal cancers
por: Vasey, P A, et al.
Publicado: (2008)

Safety and Efficacy of Video Laparoscopic Surgical Debulking of Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancers
por: Nezhat, Farr R., et al.
Publicado: (2012)

A Contribution to the Study of Hernias of the Ovary, of the Fallopian Tube and of the Ovary and Fallopian Tube
por: Heineck, Aime Paul
Publicado: (1916)

Incidence of colorectal cancer in Poland in 1999-2008
por: Klimczak, Alicja, et al.
Publicado: (2011)

Cancer incidence and mortality in Serbia 1999–2009
por: Mihajlović, Jovan, et al.
Publicado: (2013)

Cancer Incidence and Survival among Adolescents and Young Adults in Korea: An Update for 2016
por: Park, Meerim, et al.
Publicado: (2021)

Incidence, mortality, and survival of liver cancer using Korea central cancer registry database: 1999-2019
por: Hong, Sung Yeon, et al.
Publicado: (2022)

How to manage synchronous endometrial and ovarian cancer patients?
por: Shin, Wonkyo, et al.
Publicado: (2021)

Pretreatment Nutritional Status in Combination with Inflammation Affects Chemotherapy Interruption in Women with Ovarian, Fallopian Tube, and Peritoneal Cancer
por: Nomoto, Naoko, et al.
Publicado: (2022)

Cancer of the ovary, fallopian tube, and peritoneum: 2021 update
por: Berek, Jonathan S., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_i3bsijb8s1t96g1unu735og7uq